Anna Mandecka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anna Mandecka has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Weronika Komala
District Hospital in Chrzanów
6 shared publications - Dorota Plechawska5 shared publications
- Joanna Gerlach5 shared publications
- Joanna Kaźmierczak
Specialist Voivodeship Hospital of Saint Barbara No. 5 in Sosnowiec - Trauma Center
5 shared publications - Karolina Witek5 shared publications
- Kornela Kotucha-Cyl
Specialist Hospital No. 2 in Bytom, Poland
5 shared publications
Latest Publications
- Open Access
- 26 February 2026
- Published by Wiley in Clinical and Translational Science
- Vol. 19 (3) , e70513
Review of Herpes Zoster Occurrence in Patients With Atopic Dermatitis Treated With JAK Inhibitors
Atopic dermatitis ( AD ) is a chronic inflammatory skin disease that markedly impairs quality of life. Janus kinase inhibitors (upadacitinib, abrocitinib, and baricitinib) are effective therapies for moderate‐to‐severe AD but are associated with viral reactivation, particularly herpes zoster ( HZ ), due to immunosuppressive effects on interferon signaling and natural killer cell activity. The objective of this study was to systematically evaluate the risk of HZ among AD patients treated with JAK inhibitors (JAKis), identify key risk factors, and assess the clinical outcomes and management of HZ in this population. A systematic review of PubMed , Embase, and the Cochrane Library evaluated HZ risk in adolescents and adults with moderate‐to‐severe AD treated with JAK . Searches followed PRISMA guidelines using MeSH and EMTREE terms. The protocol was registered in PROSPERO ( CRD420251070483 ). Eligible English‐language studies included randomized trials, cohort studies, pooled safety analyses, and case series with ≥ 5 participants; reviews, case reports, and pediatric, animal, or in vitro studies were excluded. Data extraction was performed independently by two reviewers. The certainty of evidence was assessed using the GRADE approach. Eleven studies were included. The risk of HZ incidence appears higher in older patients. In some cases, the risk correlates with higher doses of JAK inhibitors, and a trend toward increased HZ events has been observed in Asian populations. HZ is a relevant but generally manageable adverse event in AD patients on JAKis . Risk stratification by age, dose, and comorbidities is advised. Ongoing real‐world monitoring is crucial for optimizing outcomes.
- 26 February 2026
- Published by Wiley in Clinical and Translational Science
- Vol. 19 (3) , e70513
Open AccessReview of Herpes Zoster Occurrence in Patients With Atopic Dermatitis Treated With JAK Inhibitors
Atopic dermatitis ( AD ) is a chronic inflammatory skin disease that markedly impairs quality of life. Janus kinase inhibitors (upadacitinib, abrocitinib, and baricitinib) are effective therapies for moderate‐to‐severe AD but are associated with viral reactivation, particularly herpes zoster ( HZ ), due to immunosuppressive effects on interferon signaling and natural killer cell activity. The objective of this study was to systematically evaluate the risk of HZ among AD patients treated with JAK inhibitors (JAKis), identify key risk factors, and assess the clinical outcomes and management of HZ in this population. A systematic review of PubMed , Embase, and the Cochrane Library evaluated HZ risk in adolescents and adults with moderate‐to‐severe AD treated with JAK . Searches followed PRISMA guidelines using MeSH and EMTREE terms. The protocol was registered in PROSPERO ( CRD420251070483 ). Eligible English‐language studies included randomized trials, cohort studies, pooled safety analyses, and case series with ≥ 5 participants; reviews, case reports, and pediatric, animal, or in vitro studies were excluded. Data extraction was performed independently by two reviewers. The certainty of evidence was assessed using the GRADE approach. Eleven studies were included. The risk of HZ incidence appears higher in older patients. In some cases, the risk correlates with higher doses of JAK inhibitors, and a trend toward increased HZ events has been observed in Asian populations. HZ is a relevant but generally manageable adverse event in AD patients on JAKis . Risk stratification by age, dose, and comorbidities is advised. Ongoing real‐world monitoring is crucial for optimizing outcomes.
- Open Access
- 1 January 2026
- Published by Wiley in Dermatologic Therapy
- Vol. 2026 (1)
The Use of Botulinum Toxin in the Treatment of Androgenetic Alopecia: A Systematic Review
Background: Androgenetic alopecia involves the gradual miniaturization of hair follicles, resulting in progressive hair loss. Despite its prevalence, it remains a therapeutic challenge. Current treatments, such as minoxidil and oral finasteride, have limitations. Botulinum toxin type A (BTXA) offers a complementary approach by relaxing scalp muscles, potentially improving blood flow and prolonging hair follicle lifespan. Objectives: This review aims to evaluate the therapeutic potential of BTXA in AGA treatment by analyzing recent literature. The primary focus is to assess BTXA’s effectiveness, underlying mechanisms, and safety as an adjunctive therapeutic option. Methods: A systematic search of PubMed identified studies on BTXA for AGA from the database’s inception to December 2024. Emtree and MeSH terms such as “Botulinum Toxins, Type A” and “Androgenetic Alopecia” were used along with additional combinations designed to thoroughly identify relevant studies in the field. Eleven studies met PRISMA guidelines and predefined inclusion and exclusion criteria. Results: BTXA treatment proved effective in androgenetic alopecia, increasing hair density by 13%–20% within 12–24 weeks ( p < 0.05) and improving follicle diameter by 3 months ( p < 0.001). It reduced DHT‐induced apoptosis in dermal papilla cells via anti‐inflammatory mechanisms and improved seborrhea and scalp vascularization with no significant adverse effects, supporting its role as a safe adjunctive therapy. Conclusions: BTXA improves hair density and follicle health in AGA through enhanced vascular dynamics and anti‐inflammatory actions. It is a promising adjunctive therapy requiring further studies to refine protocols and assess long‐term outcomes.
- 1 January 2026
- Published by Wiley in Dermatologic Therapy
- Vol. 2026 (1)
Open AccessThe Use of Botulinum Toxin in the Treatment of Androgenetic Alopecia: A Systematic Review
Background: Androgenetic alopecia involves the gradual miniaturization of hair follicles, resulting in progressive hair loss. Despite its prevalence, it remains a therapeutic challenge. Current treatments, such as minoxidil and oral finasteride, have limitations. Botulinum toxin type A (BTXA) offers a complementary approach by relaxing scalp muscles, potentially improving blood flow and prolonging hair follicle lifespan. Objectives: This review aims to evaluate the therapeutic potential of BTXA in AGA treatment by analyzing recent literature. The primary focus is to assess BTXA’s effectiveness, underlying mechanisms, and safety as an adjunctive therapeutic option. Methods: A systematic search of PubMed identified studies on BTXA for AGA from the database’s inception to December 2024. Emtree and MeSH terms such as “Botulinum Toxins, Type A” and “Androgenetic Alopecia” were used along with additional combinations designed to thoroughly identify relevant studies in the field. Eleven studies met PRISMA guidelines and predefined inclusion and exclusion criteria. Results: BTXA treatment proved effective in androgenetic alopecia, increasing hair density by 13%–20% within 12–24 weeks ( p < 0.05) and improving follicle diameter by 3 months ( p < 0.001). It reduced DHT‐induced apoptosis in dermal papilla cells via anti‐inflammatory mechanisms and improved seborrhea and scalp vascularization with no significant adverse effects, supporting its role as a safe adjunctive therapy. Conclusions: BTXA improves hair density and follicle health in AGA through enhanced vascular dynamics and anti‐inflammatory actions. It is a promising adjunctive therapy requiring further studies to refine protocols and assess long‐term outcomes.
- Open Access
- 30 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (4(48))
BODY TEMPERATURE MANAGEMENT IN PERIOPERATIVE AND INTENSIVE CARE: CLINICAL STRATEGIES FOR IMPROVING PATIENT OUTCOMES
In perioperative and intensive care unit settings, body temperature management represents a fundamental aspect of patient supervision, profoundly influencing the efficacy of therapeutic interventions, the risk of complications, and overall patient prognosis. This study explores thermoregulatory mechanisms, the effects of temperature deviations, methods for controlled temperature modulation, while also addressing associated economic, sociological and ethical considerations. Based on the interpretation of available scientific evidence, it has been demonstrated that unmeasured temperature fluctuations constitute a fundamental challenge in the context of intensive care unit management and perioperative care, with their complications representing a critical factor in maintaining homeostasis. This work addresses the issue of technical temperature monitoring, the importance of an individualized approach to each clinical case, as well as the role of state-of-the-art technologies and their perception by patients and their relatives in life-threatening situations. Concurrently, it examines the expenditures associated with the use of cutting-edge technologies as a limiting factor in the widespread adoption of such procedures, potentially leading to inequalities in access to care and necessitating further economic considerations. The findings indicate that effective monitoring of core body temperature represents not only a fundamental element of clinical patient care but also a critical life-saving technology at the threshold of life and death. This review underscores the urgent need for comprehensive standards in thermoregulation and highlights the limitations of current clinical algorithms. These gaps call for rigorous randomized studies to refine existing protocols and ensure their reliability and efficacy in high-risk settings.
- 30 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (4(48))
Open AccessBODY TEMPERATURE MANAGEMENT IN PERIOPERATIVE AND INTENSIVE CARE: CLINICAL STRATEGIES FOR IMPROVING PATIENT OUTCOMES
In perioperative and intensive care unit settings, body temperature management represents a fundamental aspect of patient supervision, profoundly influencing the efficacy of therapeutic interventions, the risk of complications, and overall patient prognosis. This study explores thermoregulatory mechanisms, the effects of temperature deviations, methods for controlled temperature modulation, while also addressing associated economic, sociological and ethical considerations. Based on the interpretation of available scientific evidence, it has been demonstrated that unmeasured temperature fluctuations constitute a fundamental challenge in the context of intensive care unit management and perioperative care, with their complications representing a critical factor in maintaining homeostasis. This work addresses the issue of technical temperature monitoring, the importance of an individualized approach to each clinical case, as well as the role of state-of-the-art technologies and their perception by patients and their relatives in life-threatening situations. Concurrently, it examines the expenditures associated with the use of cutting-edge technologies as a limiting factor in the widespread adoption of such procedures, potentially leading to inequalities in access to care and necessitating further economic considerations. The findings indicate that effective monitoring of core body temperature represents not only a fundamental element of clinical patient care but also a critical life-saving technology at the threshold of life and death. This review underscores the urgent need for comprehensive standards in thermoregulation and highlights the limitations of current clinical algorithms. These gaps call for rigorous randomized studies to refine existing protocols and ensure their reliability and efficacy in high-risk settings.
- Open Access
- 29 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (4(48))
A REVIEW OF INVASIVE SKIN REJUVENATION METHODS IN AESTHETIC MEDICINE
Invasive skin rejuvenation techniques such as microneedling, platelet-rich plasma (PRP), and fractional lasers are gaining popularity in aesthetic medicine. Their action is based on the stimulation of skin repair processes, primarily by stimulating collagen and elastin synthesis. Microneedling, also known as collagen induction therapy, improves skin structure and elasticity through controlled mechanical micro-damage. PRP, containing autologous growth factors, supports cellular regeneration and is used both as a monotherapy and in combination therapy. Fractional lasers—both ablative and non-ablative—operate through precise, thermal damage to the skin, enabling the treatment of wrinkles, scars, and discoloration. Despite their high effectiveness confirmed in clinical trials, limitations such as small patient groups, lack of standardized treatment protocols, and short follow-up periods hinder a comprehensive assessment of their effectiveness. The use of combined therapies demonstrates synergistic effects and may be an optimal treatment strategy for patients seeking lasting results while maintaining a high level of safety. Study Purpose and Materials: The aim of this study is to analyse clinical trials published in the PubMed database between 2008 and 2025 regarding invasive skin rejuvenation techniques. This field is a rapidly developing area of aesthetic medicine, offering new therapeutic options for patients with signs of skin aging. The study focuses on assessing the effectiveness, safety profile, and clinical indications of three main methods: microneedling, platelet-rich plasma (PRP) therapy, and fractional lasers. Summary: Microneedling, platelet-rich plasma (PRP), and fractional lasers are effective and safe methods of invasive skin rejuvenation. Their use, both as monotherapy and in combination therapies, improves skin quality and reduces wrinkles, scars, and discoloration. Despite promising clinical results, further studies with larger patient groups and standardized protocols are necessary to solidify their place in everyday aesthetic medicine practice.
- 29 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (4(48))
Open AccessA REVIEW OF INVASIVE SKIN REJUVENATION METHODS IN AESTHETIC MEDICINE
Invasive skin rejuvenation techniques such as microneedling, platelet-rich plasma (PRP), and fractional lasers are gaining popularity in aesthetic medicine. Their action is based on the stimulation of skin repair processes, primarily by stimulating collagen and elastin synthesis. Microneedling, also known as collagen induction therapy, improves skin structure and elasticity through controlled mechanical micro-damage. PRP, containing autologous growth factors, supports cellular regeneration and is used both as a monotherapy and in combination therapy. Fractional lasers—both ablative and non-ablative—operate through precise, thermal damage to the skin, enabling the treatment of wrinkles, scars, and discoloration. Despite their high effectiveness confirmed in clinical trials, limitations such as small patient groups, lack of standardized treatment protocols, and short follow-up periods hinder a comprehensive assessment of their effectiveness. The use of combined therapies demonstrates synergistic effects and may be an optimal treatment strategy for patients seeking lasting results while maintaining a high level of safety. Study Purpose and Materials: The aim of this study is to analyse clinical trials published in the PubMed database between 2008 and 2025 regarding invasive skin rejuvenation techniques. This field is a rapidly developing area of aesthetic medicine, offering new therapeutic options for patients with signs of skin aging. The study focuses on assessing the effectiveness, safety profile, and clinical indications of three main methods: microneedling, platelet-rich plasma (PRP) therapy, and fractional lasers. Summary: Microneedling, platelet-rich plasma (PRP), and fractional lasers are effective and safe methods of invasive skin rejuvenation. Their use, both as monotherapy and in combination therapies, improves skin quality and reduces wrinkles, scars, and discoloration. Despite promising clinical results, further studies with larger patient groups and standardized protocols are necessary to solidify their place in everyday aesthetic medicine practice.
- Open Access
- 26 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (4(48))
SYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES
Background: Alopecia areata (AA) is an autoimmune, non-scarring hair loss disorder with variable clinical presentations. Its pathogenesis involves immune privilege collapse of the hair follicle, CD8+ T-cell activation, and cytokine signaling—particularly IFN-γ and IL-15—via the JAK/STAT pathway. Recent studies highlight Janus kinase (JAK) inhibitors as promising therapeutic agents for moderate-to-severe AA. Objectives: This systematic review aimed to evaluate the efficacy and safety of oral JAK inhibitors in the treatment of adolescent and adult patients with AA based on studies published between 2020 and 2025. Material and Methods: Following PRISMA 2020 guidelines, a comprehensive search of PubMed, Cochrane Library, and ClinicalTrials.gov was conducted for studies assessing oral JAK inhibitors (e.g., baricitinib, ritlecitinib, deuruxolitinib) in AA. Inclusion criteria encompassed RCTs, observational studies, and interventional trials involving patients ≥12 years old with moderate-to-severe AA. Results: Ten studies met the criteria, including seven RCTs. Efficacy was measured predominantly by the Severity of Alopecia Tool (SALT) score. Baricitinib and deuruxolitinib consistently demonstrated superior outcomes compared to placebo and traditional therapies, with up to 41.5% of patients achieving SALT ≤20 at 24 weeks. Long-term data confirmed sustained benefits. Adverse events were mostly mild (e.g., URTI, headache, acne); serious events and discontinuations were rare. Conclusions: Oral JAK inhibitors represent an effective and generally well-tolerated option for treating moderate-to-severe AA. Their targeted mechanism offers advantages over traditional immunosuppressants, and accumulating long-term data support their integration into therapeutic guidelines.
- 26 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (4(48))
Open AccessSYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES
Background: Alopecia areata (AA) is an autoimmune, non-scarring hair loss disorder with variable clinical presentations. Its pathogenesis involves immune privilege collapse of the hair follicle, CD8+ T-cell activation, and cytokine signaling—particularly IFN-γ and IL-15—via the JAK/STAT pathway. Recent studies highlight Janus kinase (JAK) inhibitors as promising therapeutic agents for moderate-to-severe AA. Objectives: This systematic review aimed to evaluate the efficacy and safety of oral JAK inhibitors in the treatment of adolescent and adult patients with AA based on studies published between 2020 and 2025. Material and Methods: Following PRISMA 2020 guidelines, a comprehensive search of PubMed, Cochrane Library, and ClinicalTrials.gov was conducted for studies assessing oral JAK inhibitors (e.g., baricitinib, ritlecitinib, deuruxolitinib) in AA. Inclusion criteria encompassed RCTs, observational studies, and interventional trials involving patients ≥12 years old with moderate-to-severe AA. Results: Ten studies met the criteria, including seven RCTs. Efficacy was measured predominantly by the Severity of Alopecia Tool (SALT) score. Baricitinib and deuruxolitinib consistently demonstrated superior outcomes compared to placebo and traditional therapies, with up to 41.5% of patients achieving SALT ≤20 at 24 weeks. Long-term data confirmed sustained benefits. Adverse events were mostly mild (e.g., URTI, headache, acne); serious events and discontinuations were rare. Conclusions: Oral JAK inhibitors represent an effective and generally well-tolerated option for treating moderate-to-severe AA. Their targeted mechanism offers advantages over traditional immunosuppressants, and accumulating long-term data support their integration into therapeutic guidelines.
- Open Access
- 24 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (4(48))
OBESITY AND SOCIAL INEQUALITIES: HOW SOCIOECONOMIC FACTORS AFFECT HEALTH
Background: Obesity represents one of the greatest public health challenges of the 21st century. Its prevalence is strongly linked to socioeconomic factors rather than being solely the result of individual dietary choices or lifestyle behaviors. According to the World Health Organization (WHO), obesity is a consequence of excessive fat accumulation leading to metabolic disorders, an increased risk of cardiovascular diseases, type 2 diabetes, and premature mortality. Over the past decades, the global prevalence of obesity has risen dramatically, increasingly affecting individuals with lower socioeconomic status. This highlights the need to analyze the social determinants underlying this phenomenon. Objective: The aim of this paper was to present and analyze the current state of knowledge regarding the impact of socioeconomic factors, such as education level, income, place of residence, and access to healthcare, on the prevalence of obesity, as well as to discuss their health and social consequences. Methods: A literature review was conducted using scientific databases including PubMed and Google Scholar, as well as reports from international organizations such as the World Health Organization (WHO) and the Organisation for Economic Co-operation and Development (OECD). The search focused on recent publications examining the relationship between socioeconomic status and obesity. The review included original studies, review papers, and reports analyzing the effects of education, income, place of residence, and healthcare accessibility on obesity risk and its health outcomes. Results: The analysis revealed that individuals with lower socioeconomic status are significantly more likely to suffer from overweight and obesity. Contributing factors include limited access to healthy foods, infrastructure that promotes physical activity, preventive healthcare, and health education. Residents of areas with lower socioeconomic development are more exposed to phenomena such as “food deserts” and “food swamps,” which promote unhealthy eating habits. Furthermore, people living with obesity often experience stigma and discrimination, leading to reduced quality of life and lower treatment effectiveness. Conclusions: Obesity is not only a medical issue but also a social one, deeply rooted in socioeconomic structures. Effective prevention requires an integrated, systemic approach that combines actions in education, health policy, and urban planning. Key measures include improving access to healthy food, developing infrastructure that supports physical activity, enhancing the quality of healthcare, and reducing economic barriers. Reducing social inequalities can significantly contribute to lowering the prevalence of obesity and its long-term health consequences.
- 24 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (4(48))
Open AccessOBESITY AND SOCIAL INEQUALITIES: HOW SOCIOECONOMIC FACTORS AFFECT HEALTH
Background: Obesity represents one of the greatest public health challenges of the 21st century. Its prevalence is strongly linked to socioeconomic factors rather than being solely the result of individual dietary choices or lifestyle behaviors. According to the World Health Organization (WHO), obesity is a consequence of excessive fat accumulation leading to metabolic disorders, an increased risk of cardiovascular diseases, type 2 diabetes, and premature mortality. Over the past decades, the global prevalence of obesity has risen dramatically, increasingly affecting individuals with lower socioeconomic status. This highlights the need to analyze the social determinants underlying this phenomenon. Objective: The aim of this paper was to present and analyze the current state of knowledge regarding the impact of socioeconomic factors, such as education level, income, place of residence, and access to healthcare, on the prevalence of obesity, as well as to discuss their health and social consequences. Methods: A literature review was conducted using scientific databases including PubMed and Google Scholar, as well as reports from international organizations such as the World Health Organization (WHO) and the Organisation for Economic Co-operation and Development (OECD). The search focused on recent publications examining the relationship between socioeconomic status and obesity. The review included original studies, review papers, and reports analyzing the effects of education, income, place of residence, and healthcare accessibility on obesity risk and its health outcomes. Results: The analysis revealed that individuals with lower socioeconomic status are significantly more likely to suffer from overweight and obesity. Contributing factors include limited access to healthy foods, infrastructure that promotes physical activity, preventive healthcare, and health education. Residents of areas with lower socioeconomic development are more exposed to phenomena such as “food deserts” and “food swamps,” which promote unhealthy eating habits. Furthermore, people living with obesity often experience stigma and discrimination, leading to reduced quality of life and lower treatment effectiveness. Conclusions: Obesity is not only a medical issue but also a social one, deeply rooted in socioeconomic structures. Effective prevention requires an integrated, systemic approach that combines actions in education, health policy, and urban planning. Key measures include improving access to healthy food, developing infrastructure that supports physical activity, enhancing the quality of healthcare, and reducing economic barriers. Reducing social inequalities can significantly contribute to lowering the prevalence of obesity and its long-term health consequences.
- Open Access
- 24 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (4(48))
SOCIAL DETERMINANTS OF ADHERENCE TO DIETARY AND PHYSICAL ACTIVITY RECOMMENDATIONS AMONG ADULTS WITH OBESITY - A COMPREHENSIVE LITERATURE REVIEW (2010–2025)
Background: Adherence to dietary and physical activity recommendations is widely recognized as a cornerstone of effective obesity management. Nevertheless, despite extensive global efforts, adherence rates among adults remain persistently low. Recent evidence indicates that non-adherence is not solely the result of individual motivational or behavioral shortcomings but is deeply embedded within the broader framework of social determinants of health (SDH). Understanding how these determinants shape adherence is therefore essential for developing equitable and sustainable obesity interventions. Objective: This evidence-based narrative review aims to synthesize current knowledge on the impact of socioeconomic, cultural, psychosocial, healthcare, and digital factors on adherence to lifestyle recommendations among adults with obesity. Methods: A comprehensive literature search was conducted across PubMed, Scopus, Web of Science, PsycINFO, and CINAHL databases for studies published between 2010 and 2025. Eligible publications included quantitative, qualitative, and conceptual studies examining social determinants influencing adherence to dietary and physical activity guidance. Extracted findings were thematically analyzed and assessed according to the hierarchy of evidence (Levels I–IV). Results: Thirty peer-reviewed studies met the inclusion criteria. Across diverse settings, socioeconomic disadvantage, lower educational attainment, and financial insecurity consistently predicted poor adherence. Cultural norms, obesogenic environments, and neighborhood safety were found to shape opportunities for engaging in healthy behaviors. Psychosocial determinants - particularly social support, mental health status, and exposure to weight stigma- emerged as significant moderators of adherence. Limited access to healthcare and low health literacy were identified as key mediating factors, while digital inequities further widened adherence gaps despite the increasing role of telehealth and mHealth interventions. Conversely, higher social capital, supportive community structures, and equitable access to healthcare and technology facilitated sustained adherence to lifestyle recommendations. Conclusions: Adherence to dietary and physical activity recommendations among adults with obesity is fundamentally shaped by the social, environmental, and structural contexts in which individuals live. Addressing these determinants requires multilevel strategies that combine personalized behavioral counseling with broader policy initiatives aimed at promoting socioeconomic equity, supportive built environments, and digital inclusion. Sustainable obesity management depends not merely on changing individual behavior, but on transforming the social conditions that enable or constrain healthy living.
- 24 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (4(48))
Open AccessSOCIAL DETERMINANTS OF ADHERENCE TO DIETARY AND PHYSICAL ACTIVITY RECOMMENDATIONS AMONG ADULTS WITH OBESITY - A COMPREHENSIVE LITERATURE REVIEW (2010–2025)
Background: Adherence to dietary and physical activity recommendations is widely recognized as a cornerstone of effective obesity management. Nevertheless, despite extensive global efforts, adherence rates among adults remain persistently low. Recent evidence indicates that non-adherence is not solely the result of individual motivational or behavioral shortcomings but is deeply embedded within the broader framework of social determinants of health (SDH). Understanding how these determinants shape adherence is therefore essential for developing equitable and sustainable obesity interventions. Objective: This evidence-based narrative review aims to synthesize current knowledge on the impact of socioeconomic, cultural, psychosocial, healthcare, and digital factors on adherence to lifestyle recommendations among adults with obesity. Methods: A comprehensive literature search was conducted across PubMed, Scopus, Web of Science, PsycINFO, and CINAHL databases for studies published between 2010 and 2025. Eligible publications included quantitative, qualitative, and conceptual studies examining social determinants influencing adherence to dietary and physical activity guidance. Extracted findings were thematically analyzed and assessed according to the hierarchy of evidence (Levels I–IV). Results: Thirty peer-reviewed studies met the inclusion criteria. Across diverse settings, socioeconomic disadvantage, lower educational attainment, and financial insecurity consistently predicted poor adherence. Cultural norms, obesogenic environments, and neighborhood safety were found to shape opportunities for engaging in healthy behaviors. Psychosocial determinants - particularly social support, mental health status, and exposure to weight stigma- emerged as significant moderators of adherence. Limited access to healthcare and low health literacy were identified as key mediating factors, while digital inequities further widened adherence gaps despite the increasing role of telehealth and mHealth interventions. Conversely, higher social capital, supportive community structures, and equitable access to healthcare and technology facilitated sustained adherence to lifestyle recommendations. Conclusions: Adherence to dietary and physical activity recommendations among adults with obesity is fundamentally shaped by the social, environmental, and structural contexts in which individuals live. Addressing these determinants requires multilevel strategies that combine personalized behavioral counseling with broader policy initiatives aimed at promoting socioeconomic equity, supportive built environments, and digital inclusion. Sustainable obesity management depends not merely on changing individual behavior, but on transforming the social conditions that enable or constrain healthy living.
- Open Access
- 1 January 2024
- Published by Walter de Gruyter GmbH in Journal of Health Study and Medicine
- Vol. 2024 (1) , 321-348
Impact of Binge Eating Disorder on Patient’s Quality of Life – A Review
Background: Binge eating disorder (BED) is currently the most common form of an eating disorder. BED is characterized by the consumption of large amounts of food in a short period of time, in a manner not controlled by the sick person. Its etiology is not fully known, but it is assumed that the development of the disorder results from psychological, social, and biological factors. Objectives: The aim of the study is to systematize information about BED and raise awareness among the public and health professionals about the issue. Material and methods: This paper is based on a comprehensive review of scientific research conducted worldwide. Our conclusions are informed by the latest reports that explore various aspects of the daily lives of patients with BED. Results: BED is classified into varying degrees of severity, depending on the number of bouts of eating per week. The gold standard for diagnosis is a structured psychological assessment. BED often co-exists with overweight and obesity, increasing the risk of somatic and psychosocial complications. Dietary education is the basis of therapy, and psychotherapy is the first line of treatment. Pharmacotherapy, which includes lisdexamfetamine and antidepressant, antiepileptic, psychostimulant, and anti-obesity drugs, is an important support. Forming proper eating habits is key in BED prevention. Conclusions: The multifaceted nature of BED, which affects many aspects of patients’ lives, reduces their quality of life. Increasing social awareness, health education, and countering the stigma on those affected by this disorder are also key.
- 1 January 2024
- Published by Walter de Gruyter GmbH in Journal of Health Study and Medicine
- Vol. 2024 (1) , 321-348
Open AccessImpact of Binge Eating Disorder on Patient’s Quality of Life – A Review
Background: Binge eating disorder (BED) is currently the most common form of an eating disorder. BED is characterized by the consumption of large amounts of food in a short period of time, in a manner not controlled by the sick person. Its etiology is not fully known, but it is assumed that the development of the disorder results from psychological, social, and biological factors. Objectives: The aim of the study is to systematize information about BED and raise awareness among the public and health professionals about the issue. Material and methods: This paper is based on a comprehensive review of scientific research conducted worldwide. Our conclusions are informed by the latest reports that explore various aspects of the daily lives of patients with BED. Results: BED is classified into varying degrees of severity, depending on the number of bouts of eating per week. The gold standard for diagnosis is a structured psychological assessment. BED often co-exists with overweight and obesity, increasing the risk of somatic and psychosocial complications. Dietary education is the basis of therapy, and psychotherapy is the first line of treatment. Pharmacotherapy, which includes lisdexamfetamine and antidepressant, antiepileptic, psychostimulant, and anti-obesity drugs, is an important support. Forming proper eating habits is key in BED prevention. Conclusions: The multifaceted nature of BED, which affects many aspects of patients’ lives, reduces their quality of life. Increasing social awareness, health education, and countering the stigma on those affected by this disorder are also key.